UBS Group AG - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$23,000
+2200.0%
171
+968.8%
0.00%
Q3 2020$1,000
-93.8%
16
-95.2%
0.00%
Q2 2020$16,000
-90.0%
332
-89.8%
0.00%
Q1 2020$160,000
-76.0%
3,261
-72.0%
0.00%
Q4 2019$668,000
+2054.8%
11,642
+1252.1%
0.00%
Q3 2019$31,000
-24.4%
861
-35.6%
0.00%
Q2 2019$41,000
+925.0%
1,336
+724.7%
0.00%
Q1 2019$4,000
-60.0%
162
-78.0%
0.00%
Q4 2018$10,000
-41.2%
735
-56.9%
0.00%
Q3 2018$17,000
-46.9%
1,707
+7.6%
0.00%
Q2 2018$32,0001,5860.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$147,847,00025.39%
Affinity Asset Advisors, LLC 225,000$29,606,00015.69%
Chicago Capital Management, LLC 79,922$10,516,0008.38%
Opaleye Management Inc. 315,550$41,520,0005.42%
Board of Trustees of The Leland Stanford Junior University 265,670$34,957,0002.46%
Kellner Capital, LLC 26,357$3,468,0001.83%
SPRING CREEK CAPITAL LLC 140,000$18,421,0001.35%
AQR Arbitrage LLC 274,853$36,165,0001.27%
Magnetar Financial LLC 599,330$78,860,0001.11%
ALPINE ASSOCIATES MANAGEMENT INC. 184,221$24,240,0000.99%
View complete list of EIDOS THERAPEUTICS INC shareholders